Natalia T. Freund

Tel Aviv, TA 69978, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Monoclonal antibodies from COVID-19 convalescent patients target cryptic epitopes for broad SARS-CoV-2 neutralization.

Monoclonal antibodies from COVID-19 convalescent patients target cryptic epitopes for broad SARS-CoV-2 neutralization.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 25, 2026

Antibodies in tuberculosis: functional capacity as key determinant.

Antibodies in tuberculosis: functional capacity as key determinant.

Journal: Infection and immunity
Published: January 21, 2026

Monoclonal antibodies for Mpox: protective targets and therapeutic potential.

Monoclonal antibodies for Mpox: protective targets and therapeutic potential.

Journal: Current opinion in HIV and AIDS
Published: January 16, 2026

Modified Anti-PstS1 Bi-specific antibodies unlock potent protection against tuberculosis.

Modified Anti-PstS1 Bi-specific antibodies unlock potent protection against tuberculosis.

Journal: PLoS pathogens
Published: September 12, 2025

Early Antibody-Mediated Immunity to Tuberculosis in Mice Requires NLRP3.

Early Antibody-Mediated Immunity to Tuberculosis in Mice Requires NLRP3.

Journal: bioRxiv : the preprint server for biology
Published: August 01, 2025

Decoy antibodies block extracellular HSP70, prevent self-signaling, and inhibit melanoma cell survival.

Decoy antibodies block extracellular HSP70, prevent self-signaling, and inhibit melanoma cell survival.

Journal: Cell reports
Published: July 29, 2025

Potent neutralization by antibodies targeting the MPXV A28 protein.

Potent neutralization by antibodies targeting the MPXV A28 protein.

Journal: Nature communications
Published: June 25, 2025

Cellular and humoral immune responses to SARS-CoV2, comparing previously infected individuals who received one vaccine dose to uninfected individuals after three vaccine doses: A case-control study.

Cellular and humoral immune responses to SARS-CoV2, comparing previously infected individuals who received one vaccine dose to uninfected individuals after three vaccine doses: A case-control study.

Journal: Vaccine
Published: January 11, 2025

Unique characteristics of autoantibodies targeting MET in patients with breast and lung cancer.

Unique characteristics of autoantibodies targeting MET in patients with breast and lung cancer.

Journal: JCI insight
Published: September 27, 2024

Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy.

Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 21, 2024

β2-adrenergic signaling promotes higher-affinity B cells and antibodies.

β2-adrenergic signaling promotes higher-affinity B cells and antibodies.

Journal: Brain, behavior, and immunity
Published: March 16, 2023

Evaluation of the Ability of AlphaFold to Predict the Three-Dimensional Structures of Antibodies and Epitopes.

Evaluation of the Ability of AlphaFold to Predict the Three-Dimensional Structures of Antibodies and Epitopes.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 03, 2023
Showing 1-12 of 38

Last Updated: 09/26/2026